02/24/2026
PrepQuant™: Eliminating Variability Where It Starts
Reliable molecular test results depend on standardized specimen processing. Inconsistent extraction efficiencies, variable concentrations, and inaccurate quantification of samples destroy assay reliability, sensitivity, and reproducibility. Optimizing these steps is even more important in the preparation of genomic DNA and cfDNA samples used for measurable residual disease and liquid biopsy testing.
For 31 years, Invivoscribe has standardized molecular assays and their associated interpretation and reporting software. In recent years we have expanded our focus to address the critical upstream workflow: variability introduced during specimen processing.
We are pleased to introduce PrepQuant™, our integrated specimen processing platform, designed to standardize and automate:
• Nucleic acid extraction
• Sample concentration
• Accurate, reproducible quantification
This walkaway automation system integrates optimized reagents and software-driven process control to reduce hands-on variability, enhance workflow efficiency, and generate consistent, high-quality input material for downstream molecular testing.
The result: improved reproducibility and operational scalability, resulting in greater confidence in assay performance.
For information on availability and early access, please visit:
https://hubs.li/Q044ys6Z0